Cancer News: A Look at The Future of Targeted Therapy

older couple looking at a laptop

In the past, chemotherapy treatment was given to patients based on where in the body the cancer began, not taking in the factors of the molecular diversity of the individual patient’s cancer. Over the years, the development and advancement of the treatment for cancer has improved by applying molecular testing to determine individual patient tumors…

Read More

Colon Cancer and the Black Community: Know Your Risk

February is Black History Month and Cancer Prevention Month Inova Schar Cancer Institute oncologist Timothy Cannon, MD, recently treated a middle-aged black man with aggressive colorectal cancer. The patient is a real-life representation of new national data pointing to substantially higher rates of this disease in African Americans. Not only do African Americans have the…

Read More

Immunotherapy: Cancer Care Gets Customized

Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics.      Tiffani A. DeMarco, MS, CGC, is a board-certified…

Read More

Colon Cancer in Young Adults: Know Your Risk

Timothy L. Cannon, MD, is a member of Inova Medical Group board certified in medical oncology and hematology. He has a special interest in managing of gastrointestinal cancers. Read Dr. Cannon’s profile. March is Colorectal Cancer Awareness Month, and I always applaud efforts to raise awareness of this disease – the fourth most common cancer…

Read More